AbbVie logo

Associate Director, HEOR Strategy, Specialty

AbbVie

Mettawa, ILHybridPosted 1 day ago$141,500 - $268,500/year
Full TimeDirector & AboveResearch & ScientistPharmaceutical
Original posting ↗

Summary

The Associate Director, Health Economics & Outcomes Research (HEOR) Strategy, Specialty will serve as the strategic HEOR lead for assigned assets within the Hypothyroidism Therapeutic Area. The role will develop and advance integrated evidence strategies supporting launch readiness, value demonstration, market access, differentiation, and lifecycle management, partnering across the Integrated Brand Team and broader organization to inform asset and business decisions. As an individual contributor, the Associate Director will provide strategic and scientific leadership while leveraging V&E Centers of Excellence (COEs) and research partners for technical execution.

Job description

Responsibilities

  • Develop and evolve the integrated HEOR evidence strategy and roadmap, translating business, clinical, patient, and access evidence gaps into prioritized research initiatives aligned with asset strategy, launch milestones, and stakeholder needs.
  • Provide strategic and scientific direction across evidence-generation initiatives, including real-world evidence (RWE), patient and healthcare professional research, patient-reported outcomes, burden-of-illness and comparative-effectiveness research, and economic modeling.
  • Partner with V&E Centers of Excellence (COEs) and research partners to ensure methodological rigor, strategic alignment, prioritization, and timely evidence delivery while providing strategic direction and oversight.
  • Represent HEOR as a trusted strategic partner on cross-functional asset and launch teams, connecting insights across Commercial Marketing, Market Access, MHI/Value & Evidence, Clinical Development, Regulatory, and other relevant functions to inform integrated asset decisions.
  • Integrate and translate clinical, economic, humanistic, societal, and patient-centered evidence into a cohesive value narrative with clear implications for scientific, access, and business decision-making.
  • Anticipate changes in the payer, reimbursement, HTA, policy, and value-assessment environment and communicate implications, opportunities, risks, and recommendations to senior leaders and cross-functional decision-making forums.
  • Demonstrate leadership through influence, curiosity, and an enterprise mindset, using sound judgment and creativity to connect perspectives, build alignment, make timely decisions, and deliver in a fast-paced, ambiguous, and evolving environment.

Qualifications

  • Advanced degree in health economics or a related discipline, with a minimum of 5 years of relevant experience for candidates with a Master's degree or a minimum of 3 years of relevant experience for candidates with a PhD or other relevant doctoral degree (e.g., PharmD, MD).
  • Strong knowledge of HEOR methodologies, with experience in areas such as RWE and observational research, patient-reported outcomes, economic modeling, burden-of-illness, comparative effectiveness, patient and healthcare professional research, and/or evidence synthesis.
  • Demonstrated ability to translate asset, business, patient, and stakeholder needs into strategic evidence priorities and actionable research questions.
  • Experience supporting asset, brand, pipeline, and/or launch strategy, preferably for a pre-launch or launch-stage pharmaceutical asset.
  • Experience developing and translating evidence to support value demonstration, payer, market access, formulary, and reimbursement decision-making, with an understanding of the US payer and relevant HTA environment.
  • Proven ability to lead through influence, leverage technical experts and execution partners, and build alignment across complex cross-functional teams without formal authority.
  • Strong scientific judgment and executive communication skills, with the ability to synthesize complex information, connect the dots, and articulate a clear and cohesive story that engages senior leaders and cross-functional stakeholders.
  • Demonstrated enterprise mindset, curiosity, learning agility, and adaptability, with the ability to make sound decisions, deliver in ambiguous environments, and adapt to evolving business and organizational needs.
  • Experience in endocrinology, hypothyroidism, or another Specialty therapeutic area is a plus but not required.

This is a hybrid role based in Lake County, IL.

Requirements

  • Advanced degree in health economics or a related discipline
  • Minimum of 5 years of relevant experience with a Master's degree
  • Minimum of 3 years of relevant experience with a PhD or other relevant doctoral degree (e.g., PharmD, MD)
  • Strong knowledge of HEOR methodologies
  • Experience with RWE and observational research, patient-reported outcomes, economic modeling, burden-of-illness, comparative effectiveness, patient and healthcare professional research, and/or evidence synthesis
  • Demonstrated ability to translate asset, business, patient, and stakeholder needs into strategic evidence priorities and actionable research questions
  • Experience supporting asset, brand, pipeline, and/or launch strategy
  • Experience developing and translating evidence to support value demonstration, payer, market access, formulary, and reimbursement decision-making
  • Understanding of the US payer and relevant HTA environment
  • Proven ability to lead through influence and build alignment across complex cross-functional teams without formal authority
  • Strong scientific judgment and executive communication skills
  • Demonstrated enterprise mindset, curiosity, learning agility, and adaptability
  • Experience in endocrinology, hypothyroidism, or another Specialty therapeutic area is a plus but not required

Benefits

  • Paid time off
  • Medical, Dental & Vision
  • 401(k)
  • Long-term incentive programs

Company overview

AbbVie is a global biopharmaceutical company that discovers, develops, and markets advanced therapies for some of the world's most complex and serious diseases. Founded in 2013 as a spin-off from Abbott Laboratories, AbbVie has established itself as a leader in immunology, oncology, neuroscience, eye care, and virology. The company's flagship product, Humira (adalimumab), was one of the world's top-selling drugs for treating autoimmune conditions like rheumatoid arthritis and Crohn's disease. AbbVie maintains a robust pipeline of innovative medicines and has expanded its portfolio through strategic acquisitions, including Allergan in 2020. With research facilities across the United States and globally, AbbVie focuses on advancing science to improve patient outcomes while maintaining strong commercial operations worldwide. The company operates with a patient-centric approach and invests significantly in research and development to address unmet medical needs across multiple therapeutic areas.

Explore more jobs of your matchFind more biopharma roles with GetBioJob.